NRX Pharmaceuticals Inc
General ticker "NRXP" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $14.3M
NRX Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -37.3%.
Estimated limits based on current volatility of 7.2%: low 1.43$, high 1.62$
Factors to consider:
- Current price 34.7% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.18$, 6.89$]
- 2024-12-30 to 2025-12-30 estimated range: [1.95$, 6.13$]
Financial Metrics affecting the NRXP estimates:
- Negative: Non-GAAP EPS, $ of -3.70 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -44.06 <= 2.35
- Negative: Industry earnings per price (median), % of -15.01 <= 1.31
- Negative: 0 < Interest expense per share, $ of 0.02
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Negative: Industry operating profit margin (median), % of -70.04 <= 2.14
Short-term NRXP quotes
Long-term NRXP plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $115.80MM | $44.40MM | $27.59MM |
| Operating Income | $-115.80MM | $-44.40MM | $-27.59MM |
| Non-Operating Income | $22.73MM | $4.58MM | $-2.57MM |
| Interest Expense | $0.02MM | $0.00MM | $0.12MM |
| R&D Expense | $20.26MM | $17.03MM | $13.37MM |
| Income(Loss) | $-93.06MM | $-39.82MM | $-30.16MM |
| Taxes | $-21.35MM | $-4.58MM | $-0.01MM |
| Profit(Loss) | $-71.72MM | $-35.23MM | $-30.15MM |
| Stockholders Equity | $20.81MM | $7.41MM | $-11.73MM |
| Inventory | $0.00MM | $0.01MM | $0.00MM |
| Assets | $32.73MM | $25.82MM | $7.32MM |
| Operating Cash Flow | $-37.70MM | $-39.76MM | $-21.66MM |
| Capital expenditure | $0.01MM | $0.01MM | $0.00MM |
| Investing Cash Flow | $-0.01MM | $-0.01MM | $-0.00MM |
| Financing Cash Flow | $63.46MM | $32.21MM | $6.20MM |
| Earnings Per Share* | $-1.53 | $-0.54 | $-3.98 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.